Citations 1
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Sorenson, Eric J. , Windbank, A. J., Mandrekar, J. N., Bamlet, William R. , Appel, Stanley H. , Armon, C., Barkhaus, P. E., Bosch, P., David, William S., Feldman, Eva L. , Glass, Jonathan D. , Gutmann, Laurie , Katz, J., King, Wendy, Luciano, Carestia, McCluskey, Leo, Nash, S., Newman, D. S., Pascuzzi, R. M., Pioro, E., Sams, L. J., Scelsa, S., Simpson, Ericka P., Subramony, S. H., Tiryaki, Ezgi , Thornton, C. A., Boylan, Khrista , Simpson, Ericka, Bamlet, William R , Feldman, Eva L , Gutmann, Laurie
Neurology | November 24, 2008 | Volume: 71 | Issue: 22 | Pages: 1770-1775
